ArticleJournal of hematology & oncology2018

A phase I study of selinexor in combination with high-dose cytarabine and mitoxantrone for remission induction in patients with acute myeloid leukemia.

Amy Y Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.